Natixis’s Corvus Pharmaceuticals CRVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-800
| Closed | -$1.41K | – | 1021 |
|
|
2023
Q4 | $1.41K | Hold |
800
| – | – | ﹤0.01% | 961 |
|
|
2023
Q3 | $1.17K | Hold |
800
| – | – | ﹤0.01% | 912 |
|
|
2023
Q2 | $1.83K | Buy |
+800
| New | +$1.83K | ﹤0.01% | 952 |
|
|
2021
Q3 | – | Sell |
-27,900
| Closed | -$74K | – | 1211 |
|
|
2021
Q2 | $74K | Buy |
27,900
+11,400
| +69% | +$30.2K | ﹤0.01% | 838 |
|
|
2021
Q1 | $51K | Buy |
+16,500
| New | +$51K | ﹤0.01% | 1051 |
|